MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ORGO made $150,864K in revenue. $14,525K in net income. Net profit margin of 9.63%.

Income Overview

Revenue
$150,864K
Net Income
$14,525K
Net Profit Margin
9.63%
EPS
$0.11
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • Grant
Revenue Breakdown
    • Advanced Wound Care
    • Surgical And Sports Medicine
    • Grant

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenue
150,864 101,005 86,693 122,289
Write down of capitalized internal-use software costs
---990
Cost of goods sold
--23,723 29,648
Impairment of property and construction (note 8)
---4,711
Gross profit
--62,970 92,640
Cost of goods sold
36,251 27,630 --
Selling, general and administrative
79,743 73,810 72,509 74,239
Research and development
13,221 10,395 10,640 13,309
Write-down to fair value for asset held for sale
922 1,746 6,567 -
Total operating expenses
130,137 113,581 89,716 95,149
Income (loss) from operations
20,727 -12,576 -26,746 -2,508
Interest income (expense), net
-415 -669 -961 358
Other income, net
18 73 2 -11
Total other income (expense), net
433 742 963 -368
Net income (loss) before income taxes
21,160 -11,834 -25,783 -2,877
Income tax benefit
-407 -2,442 -6,940 947
Net income (loss) and comprehensive income (loss)
21,567 -9,392 -18,843 -3,823
Accretion of redeemable convertible preferred stock to redemption value
140 129 121 103
Cumulative dividend on redeemable convertible preferred stock
2,734 2,681 2,627 4,385
Undistributed earnings allocated to participating redeemable convertible preferred stock
4,168 ---
Net income (loss) attributable to common stockholders, basic, total
14,525 -12,202 -21,591 -234
Basic
126,881,709 126,853,536 126,295,642 -300,674.333
Earnings per share-basic
0.11 -0.1 -0.17 -0.033
Earnings per share-diluted
0.11 -0.1 -0.17 -0.033
Weighted-average common shares outstandingdiluted
130,848,995 126,853,536 126,295,642 -751,159
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Grant$377K Product$150,487K Other income, net$18K Interest income(expense), net-$415K Total revenue$150,864K Total other income(expense), net$433K Income (loss) fromoperations$20,727K Total operatingexpenses$130,137K Income tax benefit-$407K Net income (loss)before income taxes$21,160K Write-down to fair value forasset held for sale$922K Research and development$13,221K Selling, general andadministrative$79,743K Cost of goods sold$36,251K Net income (loss)and comprehensive...$21,567K Net income (loss)attributable to common...$14,525K Undistributed earningsallocated to...$4,168K Cumulative dividend onredeemable convertible...$2,734K Accretion of redeemableconvertible preferred stock...$140K

Organogenesis Holdings Inc. (ORGO)

Organogenesis Holdings Inc. (ORGO)